🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cognition and Patients With Lung Cancer

Recruitingn/aAges 18 Years - 74 YearsAllAssistance Publique - Hôpitaux de Paris
NCT07160751 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Cognitive complaints in patients treated for cancer can impact their quality of life. Studies show that these cognitive complaints may have multifactorial origins and appear at different stages of the care pathway. In a population of patients treated for confirmed localized non-small cell lung cancer (NSCLC), this study aims to detect and monitor the onset of cognitive complaints over time. The timing of the complaints during the treatment, the cognitive functions affected (memory, attention, concentration…), as well as the perceived intensity of the discomfort, will be examined. The study also explores the influence of co-factors such as mood, fatigue, socio-cultural status, and level of social vulnerability on these cognitive complaints.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patient aged 18 to 74 years * Suspected or confirmed localized and operable non-small cell lung cancer (NSCLC) * Surgical treatment with or without perioperative systemic medical therapy * Ability to independently complete self-questionnaires via the Cleanweb platform * Patients with access to a phone, tablet, or computer at home to complete the electronic self-questionnaires. Exclusion Criteria: * Known pre-existing cognitive disorders * Presence on the day of inclusion of one or more factors causing mental confusion: electrolyte imbalances, renal failure, hepatic failure, infections, bladder distension, fecal impaction * Known psychiatric or neurological diseases (e.g., multiple sclerosis, Parkinson's disease, dementia, stroke, traumatic brain injury with loss of consciousness) * Current use of neuroleptic treatments * History of cancer treatment within the past 10 years * Fibromyalgia * Individuals who cannot read French or are not French-speaking * Patients who have never attended school
💊

What it tests

  • Self-questionnaire
  • Cognitive tests
  • Assessment of the impact of social vulnerability on patient complaints
📍

Where

1 site
Hôpital Cochin - Service de pneumologie
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy